These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19336475)

  • 21. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
    Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease.
    Klos KL; Kardia SL; Ferrell RE; Turner ST; Boerwinkle E; Sing CF
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):971-8. PubMed ID: 11397706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins.
    Björnson E; Adiels M; Bergström G; Gummesson A
    Atherosclerosis; 2024 Jan; 388():117397. PubMed ID: 38102060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANRIL polymorphisms (rs1333049 and rs3217992) in relation to plasma CRP levels among in-patients with CHD.
    Reichert S; Seitter L; Schaller HG; Schlitt A; Schulz S
    Cytokine; 2020 Mar; 127():154932. PubMed ID: 31770616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
    Vega GL; Grundy SM
    J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM; Anderson JL; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2005 Aug; 150(2):243-50. PubMed ID: 16086925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.
    Rossouw JE; Cushman M; Greenland P; Lloyd-Jones DM; Bray P; Kooperberg C; Pettinger M; Robinson J; Hendrix S; Hsia J
    Arch Intern Med; 2008 Nov; 168(20):2245-53. PubMed ID: 19001202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and coronary heart disease in western Turkey.
    Onat A; Sansoy V; Yildirim B; Keleş I; Uysal O; Hergenç G
    Am J Cardiol; 2001 Sep; 88(6):601-7. PubMed ID: 11564380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype.
    Frikke-Schmidt R; Nordestgaard BG; Agerholm-Larsen B; Schnohr P; Tybjaerg-Hansen A
    J Lipid Res; 2000 Nov; 41(11):1812-22. PubMed ID: 11060351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
    ; Sarwar N; Sandhu MS; Ricketts SL; Butterworth AS; Di Angelantonio E; Boekholdt SM; Ouwehand W; Watkins H; Samani NJ; Saleheen D; Lawlor D; Reilly MP; Hingorani AD; Talmud PJ; Danesh J
    Lancet; 2010 May; 375(9726):1634-9. PubMed ID: 20452521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Patsch W; Sorlie PD; Heiss G; Bond MG; Davis CE
    Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
    Everett BM; Kurth T; Buring JE; Ridker PM
    J Am Coll Cardiol; 2006 Dec; 48(11):2235-42. PubMed ID: 17161253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.
    Thompson A; Danesh J
    J Intern Med; 2006 May; 259(5):481-92. PubMed ID: 16629854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.